Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Belumosudil”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05996627
What this trial is testing

Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease

Who this might be right for
Chronic Graft Versus Host Disease
Fred Hutchinson Cancer Center 82
Early research (Phase 1)Looking for participantsNCT07127926
What this trial is testing

Evaluation of Belumosudil Whole Tablets vs. Crushed Tablets Pharmacokinetics in Patients Suffering From Chronic GvHD

Who this might be right for
Chronic Graft Versus Host Disease
M.D. Anderson Cancer Center 8
Testing effectiveness (Phase 2)Looking for participantsNCT07006506
What this trial is testing

Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant

Who this might be right for
Graft Versus Host DiseaseGraft Vs Host DiseaseHematologic Malignancy
Memorial Sloan Kettering Cancer Center 46
Testing effectiveness (Phase 2)Study completedNCT02688647
What this trial is testing

A 2-Part, Phase 2 Open-label and Crossover Study of Belumosudil for Treatment of Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Kadmon Corporation, LLC 76
Testing effectiveness (Phase 2)Looking for participantsNCT06476132
What this trial is testing

Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients

Who this might be right for
Lung Transplant
National Institute of Allergy and Infectious Diseases (NIAID) 234
Testing effectiveness (Phase 2)Study completedNCT02106195
What this trial is testing

A Safety and Tolerability Study of Belumosudil (KD025) Treatment in Subjects With Moderately Severe Psoriasis Vulgaris

Who this might be right for
Psoriasis Vulgaris
Kadmon Corporation, LLC 8
Testing effectiveness (Phase 2)Looking for participantsNCT05922761
What this trial is testing

BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)

Who this might be right for
Bronchiolitis Obliterans SyndromeBronchiolitis ObliteransLung Diseases+1 more
Dana-Farber Cancer Institute 45
Early research (Phase 1)Active Not RecruitingNCT05806749
What this trial is testing

Immunological Tolerance in Patients With Mismatched Kidney Transplants

Who this might be right for
End Stage Kidney DiseaseImmunological ToleranceKidney Transplant Failure and Rejection+1 more
University of California, Los Angeles 16
Testing effectiveness (Phase 2)Ended earlyNCT04680975
What this trial is testing

Efficacy and Safety of Belumosudil in Subjects With Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Kadmon, a Sanofi Company 10
Testing effectiveness (Phase 2)Looking for participantsNCT07116031
What this trial is testing

Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)

Who this might be right for
Chronic Graft Versus Host Disease
Sanofi 37